According to Straits Research, The global immunoglobulins market size was valued at USD 15.79 billion in 2022. It is estimated to reach USD 31.06 billion by 2031, growing at a CAGR of 7.81% during the forecast period (2023–2031).
The Immunoglobulins Market refers to the industry focused on the production, distribution, and application of immunoglobulins (antibodies) used in the treatment of immune system disorders, infectious diseases, and neurological conditions. Immunoglobulins are glycoproteins produced by B cells that play a crucial role in immune defense by identifying and neutralizing pathogens like bacteria and viruses.
- March 2023- Celltrion and Genuv Inc., a clinical-stage biotechnology company based in Seoul focusing on drug discovery, partnered to develop novel therapeutic antibodies using Genuv's SHINE MOUSE platform.
- March 2023- Talem Therapeutics, a division of Immunoprecise Antibodies, collaborated with Libera Bio on multi-target artificial intelligence (AI)-driven antibody discovery. The partnership will employ nanotechnology, demonstrated in vivo, to deliver antibodies inside tumor cells, thereby potentially solving the medical problem.
Download Free Request Sample Report @ https://straitsresearch.com/report/immunoglobulins-market/request-sample
Market Drivers
The immunoglobulins market is experiencing steady growth due to various factors, including:
Rising prevalence of immunodeficiency disorders such as primary and secondary immunodeficiency.
Increasing awareness and diagnosis rates of immune-related disorders.
Growing demand for immunoglobulin therapies for treating neurological and hematological conditions.
Advancements in plasma-derived therapies.
Expansion of homecare facilities offering immunoglobulin treatments.
Favorable government initiatives supporting immunoglobulin therapies and reimbursement policies.
Key Developments in the Immunoglobulins Market
Increasing FDA approvals for immunoglobulin products.
Technological advancements in plasma fractionation techniques.
Rising collaborations and partnerships among key industry players to enhance product development.
Expansion of plasma collection centers to meet growing demand.
Adoption of subcutaneous immunoglobulin therapy for better patient compliance and efficacy.
Top Key Players in the Market
The immunoglobulins market is highly competitive, with several key players contributing to market growth. Major companies operating in the market include:
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Kendrion Biopharma
China Biologic Products Holdings Inc.
Reliance Life Sciences, Biotest AG
LFB S.A.
ADMA Biologics Inc.
Omrix Biopharmaceuticals LTD
Zydus Cadila
Bharat Serums and Vaccines Limited
Grifols S.A.
Segmentation Analysis of the Immunoglobulins Market
The immunoglobulins market is segmented based on product, application, and end-user.
By Product:
Intravenous Immunoglobulin
Subcutaneous Immunoglobulin
Intramuscular Immunoglobulin
By Applications:
Primary Immunodeficiency
Chronic Immune Deficiency Polyradiculoneuropathy
Secondary Immunodeficiency
Immune Thrombocytopenic Purpura
Myasthenia Gravis
Others
By End-User:
Hospitals and Clinics
Homecare
Market Trends and Emerging Opportunities
The increasing adoption of subcutaneous immunoglobulin (SCIG) therapy for chronic conditions is driving market growth.
Expansion of plasma fractionation facilities to enhance production capacity.
Rising research and development investments in innovative immunoglobulin therapies.
Growing use of immunoglobulin treatments for off-label applications, such as autoimmune diseases.
Increasing strategic collaborations among key market players for enhanced distribution networks.
Buy Now@ https://straitsresearch.com/buy-now/immunoglobulins-market
Geographic Analysis
The immunoglobulins market is witnessing significant growth across various regions, with North America leading due to high diagnosis rates and advanced healthcare infrastructure. Europe follows closely, driven by an increasing aging population and the prevalence of immunodeficiency disorders. The Asia-Pacific region is expected to experience the fastest growth due to rising healthcare investments, growing awareness, and expanding healthcare facilities.
Market Data Insights
The immunoglobulins market continues to expand with rising demand for therapeutic immunoglobulin treatments. The increasing focus on personalized medicine and targeted therapies is expected to further drive market growth. The global landscape remains dynamic, with continuous advancements shaping the future of immunoglobulin-based treatments.
Conclusion
The Immunoglobulins Market is poised for substantial growth, driven by rising immunodeficiency disorders, expanding healthcare infrastructure, and technological advancements. Key players in the industry are actively focusing on innovation and strategic collaborations to enhance their market presence. With increasing government support and favorable reimbursement policies, the market is expected to witness sustained growth in the coming years.
About Us:
Straits Research is a leading provider of business intelligence, specializing in research, analytics, and advisory services. Our comprehensive reports deliver in-depth market insights, helping businesses make informed decisions.
Contact Us:
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
